BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Futagami S, Takahashi H, Norose Y, Kobayashi M. Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites. Gut. 1998;43:168-175. [PMID: 10189839 DOI: 10.1136/gut.43.2.168] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Bégué RE, Moll A. Immunogenicity of Recombinant Helicobacter pylori Urease B Administered by Various Routes and with Different Adjuvants. Open Vaccine J 2009;2:28-32. [PMID: 20640237 DOI: 10.2174/1875035400902010028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, Vergani D. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol. 2004;40:31-39. [PMID: 14672611 DOI: 10.1016/s0168-8278(03)00501-4] [Cited by in Crossref: 89] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
3 McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol. 2000;16:24-31. [PMID: 17024012 DOI: 10.1097/00001574-200001000-00005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
4 Hirota K, Nagata K, Norose Y, Futagami S, Nakagawa Y, Senpuku H, Kobayashi M, Takahashi H. Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production. Infect Immun 2001;69:6597-603. [PMID: 11598027 DOI: 10.1128/IAI.69.11.6597-6603.2001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
5 Chmiela M, Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J Gastroenterol 2017; 23(22): 3964-3977 [PMID: 28652651 DOI: 10.3748/wjg.v23.i22.3964] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
6 Al-Hussaini AA, Al Jurayyan AN, Bashir SM, Alshahrani D. Where are we today with Helicobacter pylori infection among healthy children in Saudi Arabia? Saudi J Gastroenterol. 2019;25:309-318. [PMID: 31006713 DOI: 10.4103/sjg.sjg_531_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ahmed AFM, El-Sayad MH, Ali HS, El-Taweel HA. Impact of Coinfection with Schistosoma mansoni on the Antibody Response to Helicobacter pylori. Acta Parasitol 2021;66:857-62. [PMID: 33598776 DOI: 10.1007/s11686-020-00330-y] [Reference Citation Analysis]
8 Torres J, Camorlinga-Ponce M, Perez-Perez G, Muñoz L, Muñoz O. Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection. Clin Diagn Lab Immunol 2002;9:97-100. [PMID: 11777836 DOI: 10.1128/cdli.9.1.97-100.2002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
9 Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, Ohashi K, Shimizu M, Takahashi H, Gudis K. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis. J Gastroenterol Hepatol. 2006;21:32-40. [PMID: 16706809 DOI: 10.1111/j.1440-1746.2005.04148.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
10 Islam K, Khalil I, Ahsan CR, Yasmin M, Nessa J. Analysis of immune responses against H pylori in rabbits. World J Gastroenterol 2007; 13(4): 600-606 [PMID: 17278228 DOI: 10.3748/wjg.v13.i4.600] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Milani M, Sharifi Y, Rahmati-Yamchi M, Somi MH, Akbarzadeh A. Immunology and vaccines and nanovaccines for Helicobacter pylori infection. Expert Rev Vaccines. 2015;14:833-840. [PMID: 25645086 DOI: 10.1586/14760584.2015.1008460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
12 Zavala-Spinetti L, Breslin MB, Correa H, Begue RE. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model. Helicobacter. 2006;11:517-522. [PMID: 17083372 DOI: 10.1111/j.1523-5378.2006.00453.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
13 Gorrell RJ, Robins-Browne RM. Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect Immun 2009;77:5116-29. [PMID: 19737910 DOI: 10.1128/IAI.00547-09] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1818-1820 [DOI: 10.11569/wcjd.v11.i11.1818] [Reference Citation Analysis]
15 Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015;20:239-51. [PMID: 25728540 DOI: 10.1111/hel.12200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
16 Gong Y, Wei W, Yuan Y. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test. Diagn Microbiol Infect Dis. 2014;80:316-320. [PMID: 25284372 DOI: 10.1016/j.diagmicrobio.2014.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Wu C, Zou QM, Guo H, Yuan XP, Zhang WJ, Lu DS, Mao XH. Expression, purification and immuno-characteristics of recombination UreB protein of H. pyloriWorld J Gastroenterol 2001; 7(3): 389-393 [PMID: 11819796 DOI: 10.3748/wjg.v7.i3.389] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
18 Konieczna I, Zarnowiec P, Kwinkowski M, Kolesinska B, Fraczyk J, Kaminski Z, Kaca W. Bacterial urease and its role in long-lasting human diseases. Curr Protein Pept Sci. 2012;13:789-806. [PMID: 23305365 DOI: 10.2174/138920312804871094] [Cited by in Crossref: 105] [Cited by in F6Publishing: 79] [Article Influence: 11.7] [Reference Citation Analysis]
19 Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of Helicobacter pylori infection in patients with precancerous lesions. World J Gastroenterol 2003; 9(4): 755-758 [PMID: 12679926 DOI: 10.3748/wjg.v9.i4.755] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
20 Burne RA, Chen YM. Bacterial ureases in infectious diseases. Microbes and Infection 2000;2:533-42. [DOI: 10.1016/s1286-4579(00)00312-9] [Cited by in Crossref: 219] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
21 Londoño-Arcila P, Freeman D, Kleanthous H, O'Dowd AM, Lewis S, Turner AK, Rees EL, Tibbitts TJ, Greenwood J, Monath TP, Darsley MJ. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun 2002;70:5096-106. [PMID: 12183559 DOI: 10.1128/IAI.70.9.5096-5106.2002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
22 Bégué RE, Sadowska-Krowicka H. Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model. FEMS Immunol Med Microbiol 2010;60:142-6. [PMID: 20731722 DOI: 10.1111/j.1574-695X.2010.00726.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
23 Lohoff M, Röllinghoff M, Sommer F. Helicobacter pylori gastritis: a Th1 mediated disease? Journal of Biotechnology 2000;83:33-6. [DOI: 10.1016/s0168-1656(00)00295-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
24 Kobayashi F, Watanabe E, Nakagawa Y, Yamanishi S, Norose Y, Fukunaga Y, Takahashi H. Production of autoantibodies by murine B-1a cells stimulated with Helicobacter pylori urease through toll-like receptor 2 signaling. Infect Immun. 2011;79:4791-4801. [PMID: 21947775 DOI: 10.1128/iai.05808-11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
25 Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, Kumagai Y, Fukunaga Y, Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun. 2006;74:248-256. [PMID: 16368978 DOI: 10.1128/iai.74.1.248-256.2006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
26 Reyes VE, Peniche AG. Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion. Curr Top Microbiol Immunol 2019;421:229-65. [PMID: 31123892 DOI: 10.1007/978-3-030-15138-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]